This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.
James D. Love, Chief Operations Officer of the Institute for Protein Innovation, will discuss the method, which was developed in line with the institute's mission to generate open-source antibodies against every human extracellular and secreted protein.
Dr. Love and colleagues have developed expression platforms capable of generating high-quality antigens and antibodies. These platforms are based on prior research for high-throughput production of integral membrane and other challenging proteins. Optimized transient transfection is performed via automated processes at 1 mL and 30 mL scales, and semi-automated for larger scales in HEK and CHO cells.
Dr. Love will also discuss how the challenges associated with high throughput at larger scales are being addressed with new liquid handling platforms.